Lv48
450 积分 2024-03-05 加入
Competition and Innovation in Markets for Technology
7天前
已完结
Disclosure, venture capital and entrepreneurial spawning
18天前
已完结
Venture capitalists' decision policies across three countries: an institutional theory perspective
18天前
已完结
Organizational Sponsorship and Founding Environments: A Contingency View on the Survival of Business-Incubated Firms, 1994–2007
19天前
已完结
Bricks Without Straw: Overcoming Resource Limitations to Architect Ecosystem Leadership
3个月前
已完结
Riding the Waves of Change: Using Qualitative Comparative Analysis to Analyze Complex Growth Patterns in Entrepreneurship
3个月前
已完结
Theorizing the Multiplicity of Digital Phenomena: The Ecology of Configurations, Causal Recipes, and Guidelines for Applying QCA
3个月前
已完结
Ups and Downs: The Role of Legitimacy Judgment Cues in Practice Implementation
5个月前
已完结
Coming from a Good Pond: The Influence of a New Venture’s Founding Ecosystem on Accelerator Performance
8个月前
已完结
The Impact of Partner Organizational Structure on Innovation
8个月前
已完结
Epub 2013 Feb 20. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
皖公网安备34019202002308
